双重突变DNMT3AAML:一种独特的亚型,经历了DNA损伤增加和不良预后
Emma L Boertjes1, Sanne Massaar1, Annelieke Zeilemaker1
1Department of Hematology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.
Blood advances
|December 18, 2024
概括
突变DNMT3A通过胺DNA糖酶 (TDG) 损害了DNA修复,这是基切除修复 (BER) 中的一个关键酶. 在急性髓性白血病 (AML) 中,双重突变DNMT3A与较差的生存率和增加的DNA损伤有关.
科学领域:
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 在DNMT3A的突变是克隆造血 (CH) 和急性髓性白血病 (AML) 的早期事件.
- 甲基化细胞因子去胺的DNA损伤由基切除修复 (BER) 酶修复,包括MBD4和丁氨酸DNA糖酶 (TDG).
- 缺乏MBD4与CH,AML和高DNA损伤水平有关.
研究的目的:
- 调查突变DNMT3A是否影响TDG的DNA修复功能.
- 为了比较单个突变 (SM) 与双重突变 (DM) 的AML患者的遗传特征和生存结果,DNMT3A.
主要方法:
- 试验室试验评估DNMT3A对TDG介导的DNA修复的影响.
- 对AML患者的遗传资料和全基因组测序数据的分析.
- 在SM和DMDNMT3AAML患者组之间比较生存结果.
主要成果:
- 野生型DNMT3A增强了TDG修复活动,而突变型DNMT3A则损害了它.
- 与SM DNMT3A患者相比,患有DM DNMT3A的AML患者表现出明显的驱动突变模式和降低的整体存活率.
- 在初级DM DNMT3A AML样本中观察到DNA损伤增加的趋势,特别是当突变影响DNMT3A-TDG相互作用部位时.
结论:
- 突变DNMT3A直接干扰TDG介导的DNA修复,导致AML的基因组不稳定性.
- 在AML中存在双重DNMT3A突变与更具侵略性的疾病表型和更差的预后有关.
- 针对DNMT3A-TDG相互作用或增强TDG活动可能是AML的潜在治疗策略.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Mismatch Repair
4.8K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.8K
Nucleotide Excision Repair
3.4K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.4K
Fixing Double-strand Breaks
12.2K
The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
12.2K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


